Skip to content

    Navigation breadcrumbs

  1. Home
  2. Veterinary topics and resources
  3. All resources
  4. Domain 5 – Discontinuation of anticoagulant therapy in small animals

Library and information services

Access to electronic and print resources focused on veterinary science and animal health and services to support your study and keep up to date with clinical research.

Awards and prizes

Our awards celebrate achievements and build knowledge that contributes to evidence-based veterinary medicine.

History

We hold a unique collection of books, archives, artefacts and memorabilia which together offer an insight into the evolution of the British veterinary profession.

    Navigation breadcrumbs

  1. Home
  2. Veterinary topics and resources
  3. All resources
  4. Domain 5 – Discontinuation of anticoagulant therapy in small animals
14 June 2019

Domain 5 – Discontinuation of anticoagulant therapy in small animals

spotlight topic:

Antithrombotics in small animal veterinary practice

Domain 5 – Discontinuation of anticoagulant therapy in small animals aspirin tablesThis domain looked at appropriate approaches to use for small animal patients receiving antiplatelet or anticoagulant drugs and requiring temporary discontinuation of this therapy for the purposes of invasive procedures (e.g. surgery), and at decision-making for the complete discontinuation of anticoagulant medications. In addition, the most appropriate methodology for discontinuation of heparins was addressed. The guidelines recommend that in patients at high risk for thrombosis, anticoagulation should not be discontinued for invasive procedures although they recommend discontinuing one agent if animals are receiving dual antiplatelet therapy. In patients at low to moderate risk for thrombosis, consideration may be given for discontinuation of anticoagulation prior to invasive procedures. In patients with thrombosis in whom the underlying cause for thrombosis has resolved, indefinite treatment with anticoagulant medication is not recommended. If the underlying cause is unknown or untreatable, anticoagulant medication should be continued indefinitely. Unfractionated heparin therapy should be slowly tapered rather than discontinued abruptly. Brainard, B.M. et al. (2019) Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE): Domain 5—Discontinuation of anticoagulant therapy in small animals.  Journal of Veterinary Emergency and Critical Care, 29 (1), pp. 88-97 American College of Veterinary Emergency and Critical Care (ACVECC) consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE) guidelines under five headings: Domain 1 – Defining populations at risk Domain 2 – Defining rational therapeutic usage Domain 3 – Defining antithrombotic protocols Domain 4 – Refining and monitoring antithrombotic therapies Domain 5 – Discontinuation of anticoagulant therapy in small animals Clinical applications Online full-text available to Library members A range of library membership packages is available and MRCVS vets and RVNs can join the library for a heavily subsidised, annual fee. Image copyright attribute: Shane Maritch